Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;6(10):e749-e754.
doi: 10.1016/S2589-7500(24)00155-9. Epub 2024 Aug 29.

Mitigating the risk of artificial intelligence bias in cardiovascular care

Affiliations
Free article
Review

Mitigating the risk of artificial intelligence bias in cardiovascular care

Ariana Mihan et al. Lancet Digit Health. 2024 Oct.
Free article

Abstract

Digital health technologies can generate data that can be used to train artificial intelligence (AI) algorithms, which have been particularly transformative in cardiovascular health-care delivery. However, digital and health-care data repositories that are used to train AI algorithms can introduce bias when data are homogeneous and health-care processes are inequitable. AI bias can also be introduced during algorithm development, testing, implementation, and post-implementation processes. The consequences of AI algorithmic bias can be considerable, including missed diagnoses, misclassification of disease, incorrect risk prediction, and inappropriate treatment recommendations. This bias can disproportionately affect marginalised demographic groups. In this Series paper, we provide a brief overview of AI applications in cardiovascular health care, discuss stages of algorithm development and associated sources of bias, and provide examples of harm from biased algorithms. We propose strategies that can be applied during the training, testing, and implementation of AI algorithms to mitigate bias so that all those at risk for or living with cardiovascular disease might benefit equally from AI.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests AP has received research support from the National Institutes of Health; received grant funding from Applied Therapeutics and Gilead Sciences; received consulting fees for Tricog, Novo Nordisk, Bayer, Medtronic, Edward Lifesciences, Cytokinetics, Roche, Sarfez Pharma, Science37, Rivus, Axon Therapies, Alleviant, and Lilly; received non-financial support from Pfizer and Merck; participated on data and safety monitoring boards for Bayer, Cytokinetics, Novo Nordisk, and Medtronic; and is a consultant for Palomarin with stocks compensation. HCGV and AM declare no competing interests.

References

Publication types

LinkOut - more resources